학술논문
A Brief Report of Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: Outcomes by Tumor PD-L1 Expression in the Phase 3 POSEIDON Study
Document Type
Short Communication
Author
Garon, Edward B.; Cho, Byoung Chul; Luft, Alexander; Alatorre-Alexander, Jorge; Geater, Sarayut Lucien; Trukhin, Dmytro; Kim, Sang-We; Ursol, Grygorii; Hussein, Maen; Lim, Farah Louise; Yang, Cheng-Ta; Araujo, Luiz Henrique; Saito, Haruhiro; Reinmuth, Niels; Kohlmann, Milena; Lowery, Caitlin; Mann, Helen; Peters, Solange; Mok, Tony S.; Johnson, Melissa L.
Source
In Clinical Lung Cancer May 2024 25(3):266-273
Subject
Language
ISSN
1525-7304